Role of cardiac catheterization and percutaneous coronary intervention in the preoperative assessment and management of patients before orthotopic liver transplantation

Liver Transplantation

Volumn 20, Issue 6, 2014, Pages 664-672

  Maddur, Haripriya ^a   Bourdillon, Patrick D ^a   Liangpunsakul, Suthat ^a   Joseph Tector, A ^a   Fridell, Jonathan A ^a   Ghabril, Marwan ^a   Lacerda, Marco A ^a   Bourdillon, Charlotte ^a   Shen, Changyu ^a   Kwo, Paul Y ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; EXERCISE TEST; HEALTH CARE POLICY; HEART CATHETERIZATION; HEART INFARCTION; HUMAN; INCIDENCE; KIDNEY INJURY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; ANGIOCARDIOGRAPHY; CORONARY STENOSIS; FEMALE; LIVER DISEASES; MALE; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PREDICTIVE VALUE; PREOPERATIVE CARE; PROPORTIONAL HAZARDS MODEL; SEVERITY OF ILLNESS INDEX; TIME; TREATMENT OUTCOME; UNITED STATES;

CARDIAC CATHETERIZATION; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; EXERCISE TEST; FEMALE; HUMANS; INDIANA; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84901458478     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23873     Document Type: Article

References (24)

1. Lee SS,. Cardiac abnormalities in liver cirrhosis. West J Med 1989; 151: 530-535.
2. Murray KF, Carithers RL Jr,; for AASLD. AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology 2005; 41: 1407-1432.
3. Lentine KL, Costa SP, Weir MR, Robb JF, Fleisher LA, Kasiske BL, et al.; for American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Peripheral Vascular Disease. Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol 2012; 60: 434-480.
4. Cicognani C, Malavolti M, Morselli-Labate AM, Zamboni L, Sama C, Barbara L,. Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis. Arch Intern Med 1997; 157: 792-796.
5. Blei AT, Mazhar S, Davidson CJ, Flamm SL, Abecassis M, Gheorghiade M,. Hemodynamic evaluation before liver transplantation: insights into the portal hypertensive syndrome. J Clin Gastroenterol 2007; 41 (suppl 3): S323-S329.
6. Carey WD, Dumot JA, Pimentel RR, Barnes DS, Hobbs RE, Henderson JM, et al. The prevalence of coronary artery disease in liver transplant candidates over age 50. Transplantation 1995; 59: 859-864.
7. Tiukinhoy-Laing SD, Rossi JS, Bayram M, De Luca L, Gafoor S, Blei A, et al. Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation. Am J Cardiol 2006; 98: 178-181.
8. Yong CM, Sharma M, Ochoa V, Abnousi F, Roberts J, Bass NM, et al. Multivessel coronary artery disease predicts mortality, length of stay, and pressor requirements after liver transplantation. Liver Transpl 2010; 16: 1242-1248.
9. Kadayifci A, Tan V, Ursell PC, Merriman RB, Bass NM,. Clinical and pathologic risk factors for atherosclerosis in cirrhosis: a comparison between NASH-related cirrhosis and cirrhosis due to other aetiologies. J Hepatol 2008; 49: 595-599.
10. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P,; for Acute Dialysis Quality Initiative Workgroup. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-R212.
11. Sharma M, Yong C, Majure D, Zellner C, Roberts JP, Bass NM, et al. Safety of cardiac catheterization in patients with end-stage liver disease awaiting liver transplantation. Am J Cardiol 2009; 103: 742-746.
12. Azarbal B, Poommipanit P, Arbit B, Hage A, Patel J, Kittleson M, et al. Feasibility and safety of percutaneous coronary intervention in patients with end-stage liver disease referred for liver transplantation. Liver Transpl 2011; 17: 809-813.
13. Townsend JC, Heard R, Powers ER, Reuben A,. Usefulness of international normalized ratio to predict bleeding complications in patients with end-stage liver disease who undergo cardiac catheterization. Am J Cardiol 2012; 110: 1062-1065.
14. Bhutani S, Tobis J, Gevorgyan R, Suh W, Honda H, Steadman R,. Cardiac catheterization in patients with end stage liver disease: risks and outcomes. J Am Coll Cardiol 2012; 59: E70.
15. Pillarisetti J, Patel P, Duthuluru S, Roberts J, Chen W, Genton R, et al. Cardiac catheterization in patients with end-stage liver disease: safety and outcomes. Catheter Cardiovasc Interv 2011; 77: 45-48.
16. Raval Z, Harinstein ME, Skaro AI, Erdogan A, DeWolf AM, Shah SJ, et al. Cardiovascular risk assessment of the liver transplant candidate. J Am Coll Cardiol 2011; 58: 223-231.
17. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 2011; 124: e574-e651.
18. Wray C, Scovotti JC, Tobis J, Niemann CU, Planinsic R, Walia A, et al. Liver transplantation outcome in patients with angiographically proven coronary artery disease: a multi-institutional study. Am J Transplant 2013; 13: 184-191.
19. Ehtisham J, Altieri M, Salamé E, Saloux E, Ollivier I, Hamon M,. Coronary artery disease in orthotopic liver transplantation: pretransplant assessment and management. Liver Transpl 2010; 16: 550-557.
20. Ali A, Bhardwaj HL, Heuman DM, Jovin IS,. Coronary events in patients undergoing orthotopic liver transplantation: perioperative evaluation and management. Clin Transplant 2013; 27: E207-E215.
21. Vallance P, Moncada S,. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet 1991; 337: 776-778.
22. Harinstein ME, Flaherty JD, Ansari AH, Robin J, Davidson CJ, Rossi JS, et al. Predictive value of dobutamine stress echocardiography for coronary artery disease detection in liver transplant candidates. Am J Transplant 2008; 8: 1523-1528.
23. Plotkin JS, Benitez RM, Kuo PC, Njoku MJ, Ridge LA, Lim JW, et al. Dobutamine stress echocardiography for preoperative cardiac risk stratification in patients undergoing orthotopic liver transplantation. Liver Transpl Surg 1998; 4: 253-257.
24. Donovan CL, Marcovitz PA, Punch JD, Bach DS, Brown KA, Lucey MR, Armstrong WF,. Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation. Transplantation 1996; 61: 1180-1188.